Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The objectives of this study are to determine the cerebrospinal fluid (CSF) levels of ABT-126 and to examine the effects of ABT-126 on exploratory biomarkers after administration of a single does of ABT-126 in healthy volunteers.

Key facts

Study ID

NCT00912431

Run by

Abbott

People needed

10

Starts

2009-06-01

Last updated by the study team

2010-11-02

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or female subjects between 18 and 50 years of age

You may not qualify if…

• History of bleeding disorders or Deep Vein Thrombosis
• History of spinal surgery
• History of migraine headaches, or other types of headaches occuring more than 2 times per month, or history of spinal disc disease, or chronic, significant low back pain

Where it is running

• Site Reference ID/Investigator# 20761 — Glendale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.